Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490943 · ClinicalTrials.gov registry record · NA
A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS
A NA study, sponsored by Brown, Theodore R., M.D., MPH.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02490943: Completed NA study, sponsored by Brown, Theodore R., M.D., MPH.
NCT02490943 is a NA study that has completed, run by Brown, Theodore R., M.D., MPH. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02490943, a NA study, has completed, sponsored by Brown, Theodore R., M.D., MPH.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Peginterferon-beta-1a (PEG) is an approved treatment for relapsing forms of MS that may cause injection related erythema. This is a randomized controlled cross-over trial of superficial hot and cold modalities to reduce injection site erythema caused by PEG.
Primary Outcome
Participants will record the diameter of patch of skin discoloration in millimeters, measuring at the maximum width.
Interventions
- OTHER Warm Compress Before Injection
- OTHER Cold Compress After Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT02490943 record still lists
NCT02490943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Warm Compress Before Injection is the first listed.
NCT02490943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02490943 about?
NCT02490943 is a clinical study titled "A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS". Peginterferon-beta-1a (PEG) is an approved treatment for relapsing forms of MS that may cause injection related erythema. This is a randomized controlled cross-over trial of superficial hot and cold modalities to reduce injection site erythema caused by PEG.
What is the current status of trial NCT02490943?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-06. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT02490943?
The interventions under investigation include: Warm Compress Before Injection (OTHER), Cold Compress After Injection (OTHER).
Who is sponsoring clinical trial NCT02490943?
This trial is sponsored by Brown, Theodore R., M.D., MPH, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02490943's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia